share_log

Transcode Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Chief Executive Officer Dudley Robert Michael

Transcode Therapeutics | 4/A:持股變動聲明(修正)-首席執行官 Dudley Robert Michael

美股SEC公告 ·  2023/06/14 16:16
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息